Suppr超能文献

胸腔半野调强放疗技术在恶性胸膜间皮瘤行胸膜外全肺切除术后的应用。

Hemithoracic intensity-modulated radiotherapy using helical tomotherapy for patients after extrapleural pneumonectomy for malignant pleural mesothelioma.

机构信息

Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.

出版信息

J Radiat Res. 2012;53(2):288-94. doi: 10.1269/jrr.11130. Epub 2012 Feb 25.

Abstract

Postoperative hemithoracic irradiation is regarded as an important part of the curative treatment for resectable malignant pleural mesothelioma (MPM). Because the clinical target volume in postoperative MPM is irregular and surrounded by dose-limiting critical structures, intensity-modulated radiation therapy (IMRT) is thought to be suitable. However, postoperative hemithoracic IMRT remains experimental due to a high incidence of fatal pneumonitis. Therefore, a Phase I dose escalation study for hemithoracic IMRT using helical tomotherapy was planned, and the results of the first three patients are herein reported because this technique may provide benefits to such patients. For 3 patients with postoperative MPM, who were treated by extrapleural pneumonectomy (EPP), a radiation dose of 45.0 Gy in 25 fractions was given to cover 95% of the PTV. The lung V5s of the three patients were 14.3%, 10.0%, and 31.3%, respectively. The V5s of the present plans was smaller than that of the recent IMRT planning studies. The lung V20s of these patients were 2.4%, 2.2%, and 4.3%, respectively. Their MLDs were 4.3 Gy, 3.4 Gy, and 5.8 Gy, respectively. The follow-up periods of the patients were 26, 14 and 9 months from initiation of IMRT, respectively. All patients were alive, although local and contralateral recurrences had developed in 1 patient. Only 1 patient had Grade 2 acute esophagitis and nausea. There was no treatment-related pneumonitis. Hemithoracic IMRT using helical tomotherapy may play a crucial role in adjuvant treatment for MPM after EPP.

摘要

术后半胸放疗被认为是可切除恶性胸膜间皮瘤(MPM)的重要治疗手段之一。由于术后 MPM 的临床靶区不规则,且周围有剂量限制的关键结构,因此认为调强放疗(IMRT)是合适的。然而,由于致命性放射性肺炎的发生率较高,术后半胸 IMRT 仍处于实验阶段。因此,计划进行一项采用螺旋断层放疗的术后半胸 IMRT 的 I 期剂量递增研究,由于该技术可能对这类患者有益,故在此报告前 3 例患者的结果。3 例接受过胸膜外全肺切除术(EPP)的术后 MPM 患者,给予 45.0 Gy/25 次的放疗剂量,以覆盖 95%的 PTV。3 例患者的肺 V5s 分别为 14.3%、10.0%和 31.3%。本研究计划的 V5s 小于最近的 IMRT 计划研究。这 3 例患者的 V20s 分别为 2.4%、2.2%和 4.3%。他们的 MLDs 分别为 4.3 Gy、3.4 Gy 和 5.8 Gy。3 例患者接受 IMRT 治疗的随访时间分别为 26、14 和 9 个月。所有患者均存活,尽管 1 例患者出现局部和对侧复发。仅有 1 例患者出现 2 级急性食管炎和恶心。无治疗相关的放射性肺炎。采用螺旋断层放疗的术后半胸放疗可能在 EPP 后 MPM 的辅助治疗中发挥重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验